問題 › 競合を買収すべきか？ › 会計・アドバイザリー事務所
会計事務所の買収は価格よりも統合で失敗するケースが圧倒的に多く、請求可能時間の喪失による統合コストは最も見積もられにくい数字です。 会計事務所の場合、この問題は特定の形で現れます。答えを担う数字は実現率82％と請求可能稼働率71％であり、この業界特有の複雑さはコンプライアンス報酬の圧縮と、法定業務の出力を減らさずにアドバイザリーへ時間を移せない点にあります。一般的な問題と実際に直面している問題では、最初の対応が異なります。
会計事務所の買収は価格よりも統合で失敗するケースが圧倒的に多く、請求可能時間の喪失による統合コストは最も見積もられにくい数字です。 会計事務所の場合、この問題は特定の形で現れます。答えを担う数字は実現率82％と請求可能稼働率71％であり、この業界特有の複雑さはコンプライアンス報酬の圧縮と、法定業務の出力を減らさずにアドバイザリーへ時間を移せない点にあります。一般的な問題と実際に直面している問題では、最初の対応が異なります。
競合買収の根拠は通常、アドバイザリーサービスのクロスセルによる収益シナジーに置かれますが、これは最も信頼性が低く、到達も遅い利益です。34％というアドバイザリー獲得率を踏まえると特にそうです。一方、コンプライアンス業務の統合によるコストシナジーは予測しやすく、実現率82％がすでに報酬圧縮で圧迫されている場合、モデルが想定する規模より小さくなるのが実情です。
結果を左右する最大の数字は統合コストです。仕掛中の業務の統合、稼働率を71％以下に引き下げる人員移動、91％のコンプライアンス顧客維持を脅かす顧客離れ、そして既存の43.2m事業から経営パートナーの注意を1年以上奪う影響。これらは見積もりが難しく両社の帳簿に載らないため、日常的に省略されます。
厳格な検討では、ほかの方法でより安く構築または購入できないものを具体的に何が得られるか、そして収益シナジーが一切実現しなかった場合、210人の既存人員体制で事業がどうなるかを問います。
この3つが揃うと特徴的です。1つだけでは別のことを示すことが多いです。
✓ 根拠が買収先のコンプライアンス顧客へのアドバイザリークロスセルに依存している
✓ 統合については触れられているが、稼働率や実現率への影響がコスト化されていない
✓ 買収の動機の一部が、コンプライアンス報酬の圧縮によるコア収益の停滞にある
通常、事態を悪化させる対応です。 アドバイザリー業務からの収益シナジーで買収を評価すること。到着は遅れ、モデルより小さく、または全く実現しないのが通常です。
It is for you if you run or finance an accounting firm and the rationale leans on cross-selling to each other's customers. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 会計事務所. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Pennmark Advisory, a sample company profile used for testing rather than a customer — 43.2m total revenue with 210 fte staff.
Excerpt from a real Percision run · Quick Market Scan · sample company profile
The move. Convert 15,000 compliance hours into $1.9M incremental EBITDA by embedding advisory inside existing client relationships.
| Investment required | $0.8M-$1.2M for 6 FTE conversion specialists (salary + training); funded entirely from existing $7.8M EBITDA within 24-month payback constraint |
| Expected return | Base case: $1.9M incremental EBITDA on $1.0M investment = 1.9× return within 24 months; Low case: $1.4M EBITDA (26% lower pipeline conversion); High case: $2.4M EBITDA (26% higher win rate) |
| Revenue, year 1 | $0.6M incremental advisory revenue (partial year, 6 specialists hired Q2 2027) |
| Revenue, year 2 | $1.9M incremental EBITDA (full-year run rate) |
| Revenue, year 3 | $2.8M incremental EBITDA (additional 4 specialists funded by Year 2 cash flow) |
| Exit criteria | Strategy should be reversed if, within 18 months, (a) advisory win rate falls below 25% for two consecutive quarters, OR (b) compliance retention drops below 88%, OR (c) incremental EBITDA from conversion specialists fails to reach $800K annual run-rate by Month 18 |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to Growth Portfolio Framework, one of 29 engagements the platform runs. For 会計事務所 it works through 82% realisation rate, 71% billable utilisation, 34% advisory win rate and 91% compliance client retention, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 完全なレポートはこちらをご覧ください if you would rather see the depth first.
2回算定します。単独の価値と、自社にとっての価値です。その差が価値を生みながら支払える上限であり、想定より狭いのが普通です。
コストシナジーの方がはるかに信頼できます。自社で制御可能でスケジュールも立てやすいからです。収益シナジーは顧客の行動がモデル通りになることに依存し、それが最も誤りやすい前提です。
統合に想定以上の経営リソースが取られ、買収の回収期間中に両事業のパフォーマンスが低下することです。
Materially, yes. Compliance fee compression and inability to shift hours to advisory without reducing statutory output — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are 82% realisation rate, 71% billable utilisation, 34% advisory win rate, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on 82% realisation rate and 71% billable utilisation. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית